Scottish tech start-up Cutitronics has secured a major investment from FTSE 100 company Croda International.

Established in 2014 as a spin-out company from the University of Strathclyde, Cutitronics uses engineering and technology, known as CutiTron, to deliver personalised and adaptive skin-care.  Croda International creates and sells high-perfomance speciality ingredients for use in the cosmetics, health, and industrial sectors.

Dr David Heath, Founder and Chief Executive Officer of Cutitronics said: “Having validated CutiTron™ both technically and commercially, Croda’s support will allow us to bring our technology to market. Their longstanding reputation in delivering innovative solutions to the personal care industry is invaluable to us and we are very excited to be working together with such a responsive and forward looking company.”

Sandra Breene, President of Personal Care & North America at Croda, added: “I am delighted to be personally involved in this partnership, which will not only allow us at Croda to be part of this intelligent application platform, but it will also enable us to utilise the very latest digital technology to gain greater insight of consumer behaviour using the data the device records.

“We have long known that digitalisation will play a key role in our growth strategy, and with this wealth of information, we can continue to develop innovative and sustainable ingredients, provide better formulation support and share our knowledge with our customers as they strive to deliver the next generation of products to satisfy unmet market needs.”